ATLASATLAS fair value
ATLAS has no fair value for this stock today.
PureTech Health (PRTC.LSE)
PureTech Health share price today, ATLAS forecast and fair value
Healthcare · Biotechnology · London Stock Exchange · United Kingdom
£1.18▲ +3.51%
Prices as of Oct 27, 2026 · GBP
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on PureTech Health in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On PureTech Health
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives PureTech Health a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between £1.11 and £1.26; in 9 out of 10, between £0.985 and £1.41. Estimated annual volatility is 37%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- £285M
- Market cap (USD)
- $379M
- 52-week high
- £1.44
- 52-week low
- £1.07
- Revenue (12 months)
- $6.4M
- Net margin
- 33.2%
- Beta
- 0.81
What this means
ATLAS does not publish a fair value for PRTC.LSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks PRTC.LSE has traded between £1.07 and £1.44. Today it is 17.8% below that high and 11% above its low.
Its beta is 0.81: it tends to move less than the market.
About the company
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.
Want to see everything about PureTech Health?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does PureTech Health do?
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.
What is the chance PRTC.LSE goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, PRTC.LSE ends the month between £1.11 and £1.26.
How big is PureTech Health and what is its P/E ratio?
PureTech Health's market capitalization is £285M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is PRTC.LSE?
ATLAS estimates annual volatility at 37%. In a typical month, half of the outcomes end between £1.11 and £1.26.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer